BOLD
Price
$1.21
Change
-$0.00 (-0.00%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
27.09M
90 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$4.07
Change
-$0.00 (-0.00%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
226.29M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BOLD vs VYGR

Header iconBOLD vs VYGR Comparison
Open Charts BOLD vs VYGRBanner chart's image
Boundless Bio
Price$1.21
Change-$0.00 (-0.00%)
Volume$552
Capitalization27.09M
Voyager Therapeutics
Price$4.07
Change-$0.00 (-0.00%)
Volume$8.87K
Capitalization226.29M
BOLD vs VYGR Comparison Chart in %
BOLD
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BOLD vs. VYGR commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Buy and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (BOLD: $1.21 vs. VYGR: $4.07)
Brand notoriety: BOLD and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 45% vs. VYGR: 35%
Market capitalization -- BOLD: $27.09M vs. VYGR: $226.29M
BOLD [@Biotechnology] is valued at $27.09M. VYGR’s [@Biotechnology] market capitalization is $226.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than BOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • BOLD’s TA Score: 4 bullish, 5 bearish.
  • VYGR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both BOLD and VYGR are a bad buy in the short-term.

Price Growth

BOLD (@Biotechnology) experienced а -4.72% price change this week, while VYGR (@Biotechnology) price change was -4.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.37%. For the same industry, the average monthly price growth was +0.28%, and the average quarterly price growth was +55.43%.

Reported Earning Dates

BOLD is expected to report earnings on Mar 26, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+0.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($226M) has a higher market cap than BOLD($27.1M). VYGR has higher P/E ratio than BOLD: VYGR (6.00) vs BOLD (0.16). VYGR YTD gains are higher at: -28.219 vs. BOLD (-58.276). BOLD has higher annual earnings (EBITDA): -66.59M vs. VYGR (-136.19M). BOLD has more cash in the bank: 118M vs. VYGR (45.1M). VYGR has less debt than BOLD: VYGR (38.4M) vs BOLD (49.8M). VYGR has higher revenues than BOLD: VYGR (31.3M) vs BOLD (0).
BOLDVYGRBOLD / VYGR
Capitalization27.1M226M12%
EBITDA-66.59M-136.19M49%
Gain YTD-58.276-28.219207%
P/E Ratio0.166.003%
Revenue031.3M-
Total Cash118M45.1M262%
Total Debt49.8M38.4M130%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLDVYGR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
87%
Bullish Trend 23 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHGUF1.65N/A
N/A
Pharming Group NV
SRSLF0.16N/A
N/A
Sorrento Resources Ltd.
MSCH0.28N/A
N/A
MainStreetChamber Holdings Inc.
SMDPY11.45N/A
N/A
Sumitomo Pharma Co Ltd.
IFCZF207.89-0.88
-0.42%
Intact Financial Corp.

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with RCKT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
N/A
RCKT - BOLD
41%
Loosely correlated
+1.74%
MGNX - BOLD
38%
Loosely correlated
+1.25%
ZNTL - BOLD
37%
Loosely correlated
+2.22%
VYGR - BOLD
36%
Loosely correlated
+2.01%
DNLI - BOLD
36%
Loosely correlated
+1.07%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with KURA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+2.01%
KURA - VYGR
56%
Loosely correlated
+2.50%
RGNX - VYGR
56%
Loosely correlated
+0.77%
XNCR - VYGR
54%
Loosely correlated
-0.13%
IMNM - VYGR
54%
Loosely correlated
+2.76%
IMTX - VYGR
50%
Loosely correlated
+1.47%
More